Zentalis Pharmaceuticals Inc Sustainability Reports
Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics for cancer treatment. The company primarily targets fundamental biological pathways of cancer, including its lead candidate azenosertib.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG00R2K8TG4
4 reports from 2020 to 2025